Back to Search
Start Over
Estimated Effectiveness of JYNNEOS Vaccine in Preventing Mpox: A Multijurisdictional Case-Control Study -- United States, August 19, 2022-March 31, 2023.
- Source :
-
MMWR: Morbidity & Mortality Weekly Report . 5/19/2023, Vol. 72 Issue 20, p553-558. 6p. 3 Charts. - Publication Year :
- 2023
-
Abstract
- The article discusses the effectiveness of the JYNNEOS vaccine in preventing monkeypox (mpox) among gay, bisexual, and other men who have sex with men (MSM) and transgender individuals. Topics discussed include the approval of the JYNNEOS vaccine by the Food and Drug Administration (FDA) for the prevention of smallpox and monkeypox, the results of a matched case-control study conducted in 12 U.S. jurisdictions to evaluate the vaccine's effectiveness against monkeypox.
- Subjects :
- *VACCINES
*MONKEYPOX
*TRANSGENDER people
*SMALLPOX
Subjects
Details
- Language :
- English
- ISSN :
- 01492195
- Volume :
- 72
- Issue :
- 20
- Database :
- Academic Search Index
- Journal :
- MMWR: Morbidity & Mortality Weekly Report
- Publication Type :
- Academic Journal
- Accession number :
- 163784457